BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22028617)

  • 21. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
    Zhang H; Liu ZG; Hua XX
    Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
    Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
    Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
    Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
    Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression.
    Baugé C; Beauchef G; Leclercq S; Kim SJ; Pujol JP; Galéra P; Boumédiene K
    J Cell Mol Med; 2008; 12(5A):1754-66. PubMed ID: 18053089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma.
    Johansson E; Komuro A; Iwata C; Hagiwara A; Fuse Y; Watanabe A; Morishita Y; Aburatani H; Funa K; Kano MR; Miyazono K
    Cancer Sci; 2010 Nov; 101(11):2398-403. PubMed ID: 20718757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
    Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
    Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
    Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
    Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
    Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
    Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
    J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.
    Tarakanova VL; Wold WS
    J Virol; 2003 Sep; 77(17):9324-36. PubMed ID: 12915548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
    Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation.
    Nakano N; Tsuchiya Y; Kako K; Umezaki K; Sano K; Ikeno S; Otsuka E; Shigeta M; Nakagawa A; Sakata N; Itoh F; Nakano Y; Iemura SI; van Dinther M; Natsume T; Ten Dijke P; Itoh S
    J Biol Chem; 2017 Mar; 292(10):4099-4112. PubMed ID: 28115518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.